Published in JPEN J Parenter Enteral Nutr on November 02, 2009
Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology (2015) 1.45
Best timing for energy provision during critical illness. Crit Care (2012) 0.97
Nutritional support and brain tissue glucose metabolism in poor-grade SAH: a retrospective observational study. Crit Care (2012) 0.82
Systemic inflammatory response syndrome, the link between subarachnoid hemorrhage and caloric balance. JPEN J Parenter Enteral Nutr (2009) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
The long-term stability of the human gut microbiota. Science (2013) 5.15
Guidelines for the evaluation and management of status epilepticus. Neurocrit Care (2012) 5.00
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr (2009) 3.56
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol (2002) 3.36
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med (2004) 3.24
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08
Continuous electroencephalography in the medical intensive care unit. Crit Care Med (2009) 2.86
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell (2012) 2.46
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2005) 2.36
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 2.36
Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery (2006) 2.33
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci (2002) 2.25
Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999-2010. Am J Epidemiol (2013) 2.20
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19
External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg (2010) 2.15
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia (2002) 2.14
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev (2009) 2.11
NIH working group report: Innovative research to improve maintenance of weight loss. Obesity (Silver Spring) (2014) 2.08
Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol (2006) 2.05
Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med (2007) 1.97
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89
Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation (2005) 1.88
Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol (2011) 1.85
Ventriculostomy-related infections: a critical review of the literature. Neurosurgery (2002) 1.84
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Carotid-cavernous fistulas. Neurosurg Focus (2012) 1.76
Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med (2004) 1.76
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 1.65
Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med (2009) 1.64
Generalized periodic discharges in the critically ill: a case-control study of 200 patients. Neurology (2012) 1.64
Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 1.63
Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology (2007) 1.61
Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA (2004) 1.58
Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol (2004) 1.55
Treatment guidelines for cerebral arteriovenous malformation microsurgery. Br J Neurosurg (2009) 1.54
The surgical management of chronic subdural hematoma. Neurosurg Rev (2011) 1.54
Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg (2012) 1.53
Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery (2005) 1.51
Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol (2008) 1.51
Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery (2006) 1.49
Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset. Neurocrit Care (2007) 1.49
Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood (2009) 1.48
Safety and feasibility of percutaneous tracheostomy performed by neurointensivists. Neurocrit Care (2009) 1.47